It has become clear that increasing cAMP levels through PDE inhibition can lower the neuroinflammatory reaction while stimulating neuroplasticity; hence, this is a promising therapeutic strategy for ischemic stroke. This evidence concerns the gene ALDH7A1 and ischemic stroke.